US 8648102
Compounds for treatment of cell proliferative diseases
granted A61KA61K31/277A61K45/06
Quick answer
US patent 8648102 (Compounds for treatment of cell proliferative diseases) held by The Board of Regents of the University of Texas System expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/277, A61K45/06, A61P, A61P1/00